Get started
Author

Ali Saeedi‐Boroujeni

Observed names: A. Saeedi-Boroujeni, Ali Saeedi Boroujeni, Ali Saeedi-Boroujani, Ali Saeedi-Boroujeni, Ali Saeedi-Boroujeni‬, Ali Saeedi‑Boroujeni, Ali saeedi-Boroujeni, Saeedi-Boroujeni A, Saeedi-Boroujeni, Ali, ali saeedi Boroujeni
ORCID: 0000-0001-6167-1412
Observed ORCID: 0000-0001-6167-1412
OpenAlex ID: A5021153607
Anti-inflammatory potential of Quercetin in COVID-19 treatment
2021 · Ali Saeedi-Boroujeni, Mohammad-Reza Mahmoudian-Sani · Journal of Inflammation · 233
PDF
Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial
2021 · Gholamreza Farnoosh, Mostafa Akbariqomi, et al. · Archives of Medical Research · 94
PDF
miRNA-223 as a regulator of inflammation and NLRP3 inflammasome, the main fragments in the puzzle of immunopathogenesis of different inflammatory diseases and COVID-19
2021 · Sheyda Houshmandfar, Ali Saeedi-Boroujeni, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 61
PDF
Phytotherapy of nephrotoxicity-induced by cancer drugs: an updated review
2017 · Saeid Heidari-Soreshjani, Majid Asadi-Samani, et al. · Journal of Nephropathology · 60
PDF
COVID‐19: A Case for Inhibiting NLRP3 Inflammasome, Suppression of Inflammation with Curcumin?
2020 · Ali Saeedi‐Boroujeni, Mohammad‐Reza Mahmoudian‐Sani, et al. · Basic & Clinical Pharmacology & Toxicology · 56
Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19
2021 · Ali Saeedi-Boroujeni, Mohammad-Reza Mahmoudian-Sani, et al. · Immunopharmacology and Immunotoxicology · 45
Progranulin (PGRN) as a regulator of inflammation and a critical factor in the immunopathogenesis of cardiovascular diseases
2023 · Ali Saeedi-Boroujeni, Daryush Purrahman, et al. · Journal of Inflammation · 38
PDF
Cancer Trends in Inborn Errors of Immunity: A Systematic Review and Meta-Analysis
2024 · Saba Fekrvand, Hassan Abolhassani, et al. · Journal of Clinical Immunology · 31
PDF
Survivin as a diagnostic and therapeutic marker for thyroid cancer
2019 · Mohammad-Reza Mahmoudian-Sani, Arash Alghasi, et al. · Pathology - Research and Practice · 24
Tranilast as an Adjunctive Therapy in Hospitalized Patients with Severe COVID- 19: A Randomized Controlled Trial
2022 · Ali Saeedi-Boroujeni, Roohangiz Nashibi, et al. · Archives of Medical Research · 23
A new approach for treatment of type 1 diabetes: Phytotherapy and phytopharmacology of regulatory T cells
2017 · Mohammad Reza Mahmoudian-Sani, Majid Asadi-Samani, et al. · Journal of Renal Injury Prevention · 22
MicroRNA-122 in patients with hepatitis B and hepatitis B virus-associated hepatocellular carcinoma
2019 · Mohammad Reza Mahmoudian-Sani, Samira Asgharzade, et al. · Journal of Gastrointestinal Oncology · 21
PDF
NLRP3 inflammasome activation and oxidative stress status in the mild and moderate SARS-CoV-2 infected patients: impact of melatonin as a medicinal supplement
2021 · Hadi Esmaeili Gouvarchin Ghaleh, Abdolkarim Hosseini, et al. · Zeitschrift für Naturforschung C · 19
Diversity of malignancies in patients with different types of inborn errors of immunity
2022 · Marzieh Tavakol, Samaneh Delavari, et al. · Allergy Asthma and Clinical Immunology · 16
PDF
Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?
2021 · Mohammad Bahadoram, Bijan Keikhaei, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 16
PDF
Genetic polymorphisms associated with polycystic ovary syndrome among Iranian women
2020 · Mohammad Jamshidi, Somayeh Mohammadi Pour, et al. · International Journal of Gynecology & Obstetrics · 11
Clinical heterogeneity in families with multiple cases of inborn errors of immunity
2024 · Samaneh Delavari, Seyed Erfan Rasouli, et al. · Clinical Immunology · 10
COVID-19-induced immune thrombocytopenic purpura; Immunopathogenesis and clinical implications
2022 · Mohammad Bahadoram, Ali Saeedi-Boroujeni, et al. · Infezioni in Medicina · 10
PDF
Genetic variants and risk of thyroid cancer among Iranian patients
2021 · Mohammad Jamshidi, Gholamreza Farnoosh, et al. · Hormone Molecular Biology and Clinical Investigation · 9
Therapeutic potential of hUCMSC-derived exosomes in modulating inflammation and immune response in COVID-19-associated ARDS: A randomized clinical trial
2025 · Mofid Hosseinzadeh, Mandana Pouladzadeh, et al. · Respiratory Medicine · 7
Unraveling the immunometabolism puzzle: Deciphering systemic sclerosis pathogenesis
2024 · Maryam Masoumi, Ali Bayat Bodaghi, et al. · Heliyon · 7
Resveratrol; an inflammasome inhibitor and a potential therapy for severe cases of COVID-19
2021 · Mohammad-Reza Mahmoudian-Sani, Ali Saeedi Boroujeni, et al. · Immunopathologia Persa · 5
PDF
Polymorphisms in Genes Involved in Breast Cancer Among Iranian Patients
2021 · Gholamreza Farnoosh, Ali Saeedi-Boroujeni, et al. · Personalized Medicine · 5
NLRP3 inflammasome as a central target for the pleiotropic effects of GLP-1 receptor agonists
2026 · Ali Mahmoudi, Ali Saeedi-Boroujeni, et al. · International Immunopharmacology · 4
The genetic puzzle of rheumatoid arthritis: Causes, progression, and treatment
2025 · Maryam Masoumi, Mahdi Solaymani, et al. · Biochemistry and Biophysics Reports · 4
Works count: 53
Citation count: 859
H-index: 15
I10-index: 18
Year
Topic
Type